XML 83 R66.htm IDEA: XBRL DOCUMENT v3.25.1
Financing Agreement - Narrative (Details) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended 12 Months Ended
Feb. 24, 2025
Aug. 07, 2024
Mar. 31, 2025
Mar. 31, 2025
Mar. 31, 2024
Sep. 30, 2024
Line of Credit Facility [Line Items]            
Repayments of credit facility       $ 151,625 $ 0  
Sarepta | Sarepta Collaboration Agreement            
Line of Credit Facility [Line Items]            
Upfront payment $ 500,000          
Financing Agreement | Line of Credit            
Line of Credit Facility [Line Items]            
Debt instrument term   7 years        
Interest rate   15.00%        
Secured Debt | Financing Agreement | Line of Credit            
Line of Credit Facility [Line Items]            
Maximum borrowing capacity   $ 500,000        
Long-term line of credit   400,000        
Line of credit facility, remaining borrowing capacity   $ 100,000        
Repayments of credit facility     $ 151,625     $ 0
Debt instrument, covenant, minimum liquidity cash, cash equivalents and investments     100,000 100,000    
Market capitalization threshold     1,500,000 1,500,000    
Principal repayment schedule through fifth year     160,000 $ 160,000    
Secured Debt | Financing Agreement | Line of Credit | GSK-HBV Agreement            
Line of Credit Facility [Line Items]            
Repayments of credit facility     $ 1,600      
Repayments of debt, percentage of milestone payment     65.00%      
Secured Debt | Financing Agreement, Amendment | Line of Credit            
Line of Credit Facility [Line Items]            
Repayments of credit facility     $ 150,000